Clinical Trials Directory

Trials / Completed

CompletedNCT01222585

Metronidazole Pharmacokinetics (PK) in Premature Infants

Safety and Pharmacokinetics of Multiple Dose Metronidazole in Premature Infants

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Michael Cohen-Wolkowiez · Academic / Other
Sex
All
Age
90 Days
Healthy volunteers
Not accepted

Summary

Yearly in the United States over 500,000 newborns are delivered prematurely. This population is at high risk of catastrophic bowel disease known as necrotizing enterocolitis. Infants with necrotizing enterocolitis are at high risk of death, and survivors are at increased risk of mental retardation. Metronidazole is an antibiotic that is often administered to infants with suspected or confirmed necrotizing enterocolitis. Unfortunately, the appropriate dose of metronidazole in premature infants has not been established and it is likely to be different from older children and adults. The investigators will investigate the appropriate metronidazole dose in very premature infants by: 1) determining how premature infants eliminate metronidazole from the body and 2) determining the safest and most effective dose of metronidazole in premature infants. The investigators hypothesis are: 1) The rate of removal of metronidazole will increase with infant maturity and 2) an appropriate metronidazole dosing regimen will result in necessary drug levels to treat bacteria involved in necrotizing enterocolitis.

Conditions

Interventions

TypeNameDescription
DRUGMetronidazoleMetronidazole will be administered intravenously to premature infants as a 15 mg/kg loading dose followed by maintenance doses of 7.5 mg/kg every 12 hours for infants with \>=14 postnatal days and every 24 hours for infants \<14 postnatal days.

Timeline

Start date
2011-01-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2010-10-18
Last updated
2014-02-06
Results posted
2013-12-18

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01222585. Inclusion in this directory is not an endorsement.